资源类型：
会议/期刊
收录情况：
◇ SCIE
◇ CPCI(ISTP)
文章类型：
会议摘要
作者：
Sheng, Xinan
*
;
He, Zhisong
;
Shi, Yanxia
;
Luo, Hong
;
Han, Weiqing
;
Yao, Xin
;
Shi, Benkang
;
Liu, Jiyan
;
Hu, Changlu
;
Liu, Ziling
;
Guo, Hongqian
;
Yu, Guohua
;
Ji, Zhigang
;
Yu, Shiying
;
Hu, Yi
;
Guo, Jianming
;
Ying, Jianming
;
Fang, Jianmin
;
Zhou, Aiping
;
Guo, Jun
;
单位：
[1]Beijing Canc Hosp, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Genitourinary Oncol, Beijing, Peoples R China
[2]Peking Univ, Peking Univ Hosp 1, Inst Urol, Dept Urol, Beijing, Peoples R China
[3]Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China
[4]Chongqing Univ Canc Hosp, Chongqing Canc Hosp, Chongqing, Peoples R China
[5]Cent South Univ, Affiliated Canc Hosp, Hunan Canc Ctr, Xiangya Sch Med, Changsha, Peoples R China
[6]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China
[7]Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[8]Sichuan Univ, West China Hosp, Chengdu, Peoples R China
四川大学华西医院
[9]Anhui Canc Hosp, Hefei, Peoples R China
[10]Jilin Univ, Hosp 1, Dept Tumor Ctr, Changchun, Peoples R China
[11]Nanjing Drum Tower Hosp, Nanjing, Peoples R China
[12]Weifang Peoples Hosp, Weifang, Peoples R China
[13]Peking Union Med Coll Hosp, Beijing, Peoples R China
[14]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
华中科技大学同济医学院附属同济医院
[15]Chinese PLA Gener Hosp, Beijing, Peoples R China
[16]Fudan Univ, Shanghai Zhongshan Hosp, Shanghai, Peoples R China
[17]Chinese Acad Med Sci & Peking Union Med Coll, Pathol Dept, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[18]Tonji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
[19]Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Melanoma & Sarcoma, Beijing, Peking, Peoples R China
出处：
JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
ISSN：
0732-183X
被引次数：
21
WOS：
WOS:000863680301341
中科院(CAS)分区：
出版当年[2021]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
最新[2025]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
影响因子：
42.1
最新[2023版]
37.4
最新五年平均
44.544
出版当年[2020版]
33.883
出版当年五年平均
32.956
出版前一年[2019版]
50.739
出版后一年[2021版]
第一作者：
Sheng, Xinan
推荐引用方式(GB/T 7714)：
Sheng Xinan,He Zhisong,Shi Yanxia,et al.RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA：
Sheng, Xinan,He, Zhisong,Shi, Yanxia,Luo, Hong,Han, Weiqing...&Guo, Jun.(2022).RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Sheng, Xinan,et al."RC48-ADC for metastatic urothelial carcinoma with HER2-positive: Combined analysis of RC48-C005 and RC48-C009 trials".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)
医学